(Q36395045)

13 August 2017

1 reference

title

The value of radiotherapy in treating recurrent prostate cancer after radical prostatectomy (English)

1 reference

Adaptive radiation therapy

13 August 2017

main subject

0 references

1 reference

Andrew J Stephenson

1

1 reference

13 August 2017

Kevin M Slawin

series ordinal

2

1 reference

13 August 2017

language of work or name

English

0 references

publication date

1 December 2004

1 reference

13 August 2017

published in

Nature Reviews Urology

1 reference

13 August 2017

volume

1

1 reference

13 August 2017

issue

2

1 reference

13 August 2017

page(s)

90-96

1 reference

https://scigraph.springernature.com/pub.10.1038/ncpuro0056

13 August 2017

exact match

0 references

cites work

A nationwide charge comparison of the principal treatments for early stage prostate carcinoma

1 reference

https://api.crossref.org/works/10.1038%2FNCPURO0056

Prostate specific antigen only progression of prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPURO0056

Cancer control with radical prostatectomy alone in 1,000 consecutive patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPURO0056

Cancer progression and survival rates following anatomical radical retropubic prostatectomy in 3,478 consecutive patients: long-term results

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPURO0056

Biological determinants of cancer progression in men with prostate cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPURO0056

Defining prostate specific antigen progression after radical prostatectomy: what is the most appropriate cut point?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPURO0056

Natural history of progression after PSA elevation following radical prostatectomy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPURO0056

Surrogate end point for prostate cancer-specific mortality after radical prostatectomy or radiation therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPURO0056

Natural history of bone complications in men with prostate carcinoma initiating androgen deprivation therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPURO0056

Evaluation and management of men whose radical prostatectomies failed: results of an international survey

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPURO0056

Evaluation of serum prostate-specific antigen velocity after radical prostatectomy to distinguish local recurrence from distant metastases

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPURO0056

Patterns of secondary cancer treatment for biochemical failure following radical prostatectomy: data from CaPSURE.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPURO0056

Local recurrence after radical prostatectomy: correlation of US features with prostatic fossa biopsy findings

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPURO0056

Salvage radiotherapy for recurrent prostate cancer after radical prostatectomy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPURO0056

Salvage radiotherapy for rising or persistent PSA after radical prostatectomy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPURO0056

Is anastomotic biopsy necessary before radiotherapy after radical prostatectomy?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPURO0056

Predictors of biochemical outcome with salvage conformal radiotherapy after radical prostatectomy for prostate cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPURO0056

Treatment outcome with adjuvant and salvage irradiation after radical prostatectomy for prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPURO0056

Durable efficacy of early postoperative radiation therapy for high-risk pT3N0 prostate cancer: the importance of radiation dose

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPURO0056

Salvage radiation for a rising PSA following radical prostatectomy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPURO0056

The efficacy of postprostatectomy radiotherapy in patients with an isolated elevation of serum prostate-specific antigen

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPURO0056

High-dose intensity modulated radiation therapy for prostate cancer: early toxicity and biochemical outcome in 772 patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPURO0056

Dose escalation with three-dimensional conformal radiation therapy affects the outcome in prostate cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPURO0056

Salvage radiotherapy for biochemical failure of radical prostatectomy: a single-institution experience

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPURO0056

Long-term biochemical disease-free and cancer-specific survival following anatomic radical retropubic prostatectomy. The 15-year Johns Hopkins experience

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPURO0056

7 January 2021

Long-Term (15 Years) Results After Radical Prostatectomy For Clinically Localized (Stage T2c Or Lower) Prostate Cancer

1 reference

https://api.crossref.org/works/10.1038%2FNCPURO0056

7 January 2021

Recurrence patterns after radical retropubic prostatectomy: clinical usefulness of prostate specific antigen doubling times and log slope prostate specific antigen

1 reference

https://api.crossref.org/works/10.1038%2FNCPURO0056

7 January 2021

A randomized trial comparing radical prostatectomy with watchful waiting in early prostate cancer

1 reference

https://api.crossref.org/works/10.1038%2FNCPURO0056

7 January 2021

Clinical utility of indium 111-capromab pendetide immunoscintigraphy in the detection of early, recurrent prostate carcinoma after radical prostatectomy

1 reference

https://api.crossref.org/works/10.1038%2FNCPURO0056

7 January 2021

Prostate Specific Antigen and Local Recurrence after Radical Prostatectomy

1 reference

https://api.crossref.org/works/10.1038%2FNCPURO0056

7 January 2021

Prediction of response to salvage radiation therapy in patients with prostate cancer recurrence after radical prostatectomy

1 reference

https://api.crossref.org/works/10.1038%2FNCPURO0056

7 January 2021

Suspected local recurrence after radical prostatectomy: endorectal coil MR imaging

1 reference

https://api.crossref.org/works/10.1038%2FNCPURO0056

7 January 2021

Radiotherapy for isolated serum prostate specific antigen elevation after prostatectomy for prostate cancer

1 reference

https://api.crossref.org/works/10.1038%2FNCPURO0056

7 January 2021

Indium-111-capromab pendetide radioimmunoscintigraphy and prognosis for durable biochemical response to salvage radiation therapy in men after failed prostatectomy

1 reference

https://api.crossref.org/works/10.1038%2FNCPURO0056

7 January 2021

Long-term results of radiation therapy for prostate cancer recurrence following radical prostatectomy

1 reference

https://api.crossref.org/works/10.1038%2FNCPURO0056

7 January 2021

Consensus statements on radiation therapy of prostate cancer: guidelines for prostate re-biopsy after radiation and for radiation therapy with rising prostate-specific antigen levels after radical prostatectomy. American Society for Therapeutic Radi

1 reference

https://api.crossref.org/works/10.1038%2FNCPURO0056

7 January 2021

Radiotherapy for a rising prostate-specific antigen after radical prostatectomy: the first 10 years

1 reference

https://api.crossref.org/works/10.1038%2FNCPURO0056

7 January 2021

Salvage radiotherapy after radical prostatectomy for prostate adenocarcinoma: analysis of efficacy and prognostic factors

1 reference

https://api.crossref.org/works/10.1038%2FNCPURO0056

7 January 2021

Adjuvant radiation therapy does not cause urinary incontinence after radical prostatectomy: results of a prospective randomized study

1 reference

https://api.crossref.org/works/10.1038%2FNCPURO0056

7 January 2021

Identifiers

DOI

10.1038/NCPURO0056

1 reference

13 August 2017

1 reference